Do Interventions to Reduce Coronary Heart Disease Reduce the Incidence of Type 2 Diabetes? A Possible Role for Inflammatory Factors
- 23 January 2001
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 103 (3) , 346-347
- https://doi.org/10.1161/01.cir.103.3.346
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes MellitusNew England Journal of Medicine, 2000
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- Impact of Diabetes on Mortality After the First Myocardial InfarctionDiabetes Care, 1998
- Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)Diabetes Care, 1997
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemiaMetabolism, 1995
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.Journal of Clinical Investigation, 1995
- Regulation of the Acute Phase Response by CytokinesPerspectives in Biology and Medicine, 1993